Literature DB >> 19231702

[Use of resources and costs profile in patients with fibromyalgia or generalized anxiety disorder in primary care settings].

Antoni Sicras-Mainar1, Milagrosa Blanca-Tamayo, Ruth Navarro-Artieda, Javier Rejas-Gutiérrez.   

Abstract

OBJECTIVE: To determine the use of services and costs in patients with Fibromyalgia (FM) or Generalized Anxiety Disorder (GAD) followed up in Primary Care (PC).
DESIGN: A retrospective multicenter population-based study.
SETTING: Five primary care clinics managed by Badalona Health Service. PARTICIPANTS: Patients over 18 years seen in the 5 PC centers during the year 2006. Patients with and without GAD/FM were compared. MEASUREMENTS: Main outcomes measures were general, case/co-morbidity, health care use and primary care cost (visits, diagnostic/therapeutic tests and drugs). STATISTICAL ANALYSIS: logistic regression and ANCOVA (P<.05).
RESULTS: There was a total of 63,349 patients, 1.4% (95% CI, 0.6%-2.2%) had a diagnosis of FM, and 5.3% (95% CI, 4.5%-6.1%) GAD. The average episodes/year and visits /year was higher in FM group compared to GAD group, with a marked difference observed vs. the reference group (8.3 vs. 7.2 and 4.6 episodes/year; and 12.9 vs. 12.1 and 7.4 visits/year; P <.001). FM was shown to be related to female gender (odds ratio [OR] = 16.8), dyslipidemia (OR = 1.5), and depressive syndrome (OR = 3.9) (P <.001 in all cases). GAD was related to age (OR = 1.1), female gender (OR = 2.2), high blood pressure (OR = 1.3), dyslipidemia (OR=1.2), smoking (OR = 1.4), depressive syndrome (OR = 1.2), and cardiovascular events (OR = 1.3) (P<.02 in all cases). After adjusting for age, gender and co-morbidities, mean annual direct ambulatory cost was 555.58 Euro for the reference group, 817.37 Euro for GAD, and 908.67 Euro for FM (P<.001).
CONCLUSIONS: Compared with reference group, a considerable use of health resources and costs was observed in patients with FM or TAG in medical practice in PC settings.

Entities:  

Mesh:

Year:  2009        PMID: 19231702      PMCID: PMC7021968          DOI: 10.1016/j.aprim.2008.09.008

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  26 in total

Review 1.  How should cost data in pragmatic randomised trials be analysed?

Authors:  S G Thompson; J A Barber
Journal:  BMJ       Date:  2000-04-29

Review 2.  [Fibromyalgia: a Cinderella diagnosis].

Authors:  E Soriano Suárez; M J Gelado Ferrero; M R Girona Bastus
Journal:  Aten Primaria       Date:  2000-10-15       Impact factor: 1.137

3.  The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada.

Authors:  K P White; M Speechley; M Harth; T Ostbye
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

4.  Evaluation of the quality of life in Brazilian women with fibromyalgia, through the medical outcome survey 36 item short-form study.

Authors:  J E Martinez; I S Barauna Filho; K Kubokawa; I S Pedreira; L A Machado; G Cevasco
Journal:  Disabil Rehabil       Date:  2001-01-20       Impact factor: 3.033

5.  Prevalence of generalized anxiety disorder in general practice in Denmark, Finland, Norway, and Sweden.

Authors:  Povl Munk-Jørgensen; Christer Allgulander; Alv A Dahl; Leslie Foldager; Marthin Holm; Ib Rasmussen; Anti Virta; Marja-Terttu Huuhtanen; Hans-Ulrich Wittchen
Journal:  Psychiatr Serv       Date:  2006-12       Impact factor: 3.084

6.  Preliminary criteria for primary fibromyalgia syndrome (PFS): multivariate analysis of a consecutive series of PFS, other pain patients, and normal subjects.

Authors:  M B Yunus; A T Masi; J C Aldag
Journal:  Clin Exp Rheumatol       Date:  1989 Jan-Feb       Impact factor: 4.473

7.  Predicting resource utilization in a Veterans Health Administration primary care population: comparison of methods based on diagnoses and medications.

Authors:  Terry L Wahls; Mitchell J Barnett; Gary E Rosenthal
Journal:  Med Care       Date:  2004-02       Impact factor: 2.983

8.  [Differences in sociodemographic, clinical, psychosocial and health care characteristics between men and women diagnosed with fibromyalgia].

Authors:  I Ruiz Pérez; M C Ubago Linares; M J Bermejo Pérez; J Plazaola Castaño; A Olry de Labry-Lima; E Hernández Torres
Journal:  Rev Clin Esp       Date:  2007-10       Impact factor: 1.556

9.  Development and application of a population-oriented measure of ambulatory care case-mix.

Authors:  J P Weiner; B H Starfield; D M Steinwachs; L M Mumford
Journal:  Med Care       Date:  1991-05       Impact factor: 2.983

10.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.

Authors:  F Wolfe; H A Smythe; M B Yunus; R M Bennett; C Bombardier; D L Goldenberg; P Tugwell; S M Campbell; M Abeles; P Clark
Journal:  Arthritis Rheum       Date:  1990-02
View more
  6 in total

1.  [Comparison between aquatic-biodanza and stretching for improving quality of life and pain in patients with fibromyalgia].

Authors:  María del Mar López-Rodríguez; Adelaida María Castro-Sánchez; Manuel Fernández-Martínez; Guillermo A Matarán-Peñarrocha; María Encarnación Rodríguez-Ferrer
Journal:  Aten Primaria       Date:  2012-05-15       Impact factor: 1.137

2.  Healthcare Costs Associated With Chronic Opioid Use and Fibromayalgia Syndrome.

Authors:  Jacob T Painter; Leslie J Crofford; J S Butler; Jeffery Talbert
Journal:  Am J Pharm Benefits       Date:  2015-02-13

3.  Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors.

Authors:  Enrique Álvarez; José M Olivares; José L Carrasco; Vanessa López-Gómez; Javier Rejas
Journal:  Ann Gen Psychiatry       Date:  2015-01-22       Impact factor: 3.455

4.  Work, family and social environment in patients with Fibromyalgia in Spain: an epidemiological study: EPIFFAC study.

Authors:  Antonio Collado; Emili Gomez; Rosa Coscolla; Ruth Sunyol; Emília Solé; Javier Rivera; Emília Altarriba; Jordi Carbonell; Xavier Castells
Journal:  BMC Health Serv Res       Date:  2014-11-11       Impact factor: 2.655

5.  Satisfaction With Chronic Pain Treatment.

Authors:  Parisa Islami Parkoohi; Kimia Amirzadeh; Vahid Mohabbati; Gholamreza Abdollahifard
Journal:  Anesth Pain Med       Date:  2015-08-22

6.  Prevalence and Incidence of Patients With Fibromyalgia in Catalonia Between 2010 and 2017: A Descriptive Observational Study.

Authors:  Glòria Sauch Valmaña; Queralt Miró Catalina; Josep Vidal-Alaball
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.